Please assess the completion status of the following clinical trial:

Trial Title: Safety and Performance of Muscle Activation for Critical Care Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is enrolled within 60 hours of admission to the ICU~* Patient expected to be subject to bedrest in the ICU for \> 96 hours~Exclusion Criteria:~* Patient is age \< 18 years at time of consent~* Patient is pregnant~* Patient is moribund~* Patient has an implanted pacemaker/defibrillator~* Patient has a documented diagnosis of epilepsy~* Patient has implanted femoral rods~* Patient has leg or pelvic trauma that limits mobility~* Patient has recent trauma resulting in GCS \< 5~* Patient lacks ability to walk without assistance prior to acute ICU admission~* Patient has neuromuscular disease or abnormalities~* Patient is morbidly obese (BMI \> 40)~* Patient has a cognitive impairment or inability to follow commands prior to acute ICU admission~* Patient was transferred after \> 48 hours at another acute care institution~* Enrollment in another investigational device or drug trial that could compromise the conduct or results of the study~* Evidence of disease or condition that, in the opinion of the physician, may compromise the conduct of or results of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Activation Treatment (Type: EXPERIMENTAL): None
- Usual Care (Type: NO_INTERVENTION): This arm will not receive any study-motivated intervention. Subjects will receive usual care, but will participate in outcomes assessments.

Based on this trial design, predict the completion outcome and termination type (if applicable).